Credit Agricole
CORT icon

Credit Agricole’s Corcept Therapeutics CORT Stock Holding History

Credit Agricole’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,335
Closed -$603K – 1294
2025
Q4 		$603K Hold
17,335
– – ﹤0.01% 1142
2025
Q3 		$1.44M Buy
+17,335
New +$1.25M ﹤0.01% 867
2025
Q1 		$1.98M Buy
+17,335
New +$1.06M 0.01% 747
2017
Q2 		– Sell
-29,538
Closed -$324K – 1448
2017
Q1 		$324K Sell
29,538
-59,077
-67% -$519K ﹤0.01% 1465
2016
Q4 		$643K Buy
+88,615
New +$694K ﹤0.01% 1185

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Credit Agricole's CORT Position: Q1 2026 in Review

Credit Agricole sold out of Corcept Therapeutics (CORT) in Q1 2026, closing a stake of 17,335 shares — an estimated $603K sold.

Credit Agricole first reported a position in CORT in Q4 2016 and held it in 5 quarters. The position peaked at $1.98M in Q1 2025. 352 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • Credit Agricole reported no remaining Corcept Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Credit Agricole sold 17,335 Corcept Therapeutics shares in Q1 2026, an estimated $603K.
  • Credit Agricole first reported a position in Corcept Therapeutics in Q4 2016 and held it in 5 quarters.
  • Credit Agricole's Corcept Therapeutics position peaked at $1.98M in Q1 2025.
  • 352 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.